Stockscreener 앱 받기
1.82
0.55%
-0.01
시간 외 거래:
1.82
Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Sees Large Increase in Short Interest - MarketBeat
“Top Biotech Opportunities: RVNC, HCTI, GLUE, PRSO, CRDL, Showing Promising Developments” - The Globe and Mail
Equities Analysts Set Expectations for CRDL Q3 Earnings - MarketBeat
HC Wainwright Issues Negative Outlook for CRDL Earnings - Defense World
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Shares Acquired by Foundations Investment Advisors LLC - Defense World
HC Wainwright Reiterates "Buy" Rating for Cardiol Therapeutics (NASDAQ:CRDL) - MarketBeat
Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year? - MSN
Cardiol Therapeutics advances CardiolRx in new trial By Investing.com - Investing.com Australia
Cardiol Therapeutics' (NASDAQ: CRDL) CardiolRx Trademark - openPR
Cardiol Therapeutics to expand clinical program for recurrent pericarditis with MAVERIC-2 trial - Proactive Investors Australia
Cardiol Therapeutics advances CardiolRx in new trial - Investing.com
Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis - Newsfile
Troutman Pepper Advises Cardiol Therapeutics in Closing of Over-Allotment Option - Troutman Pepper
Cardiol Therapeutics (FRA:CT9) Operating Cash Flow per Shar - GuruFocus.com
Gold SPDR (GLD-A) QuotePress Release - The Globe and Mail
Deeper Dive: Understanding Cardiol Therapeutics Inc (CRDL) Through its Various Ratios - The Dwinnex
Cardiol Therapeutics raises $15.5M following over-allotment option exercise - Proactive Investors USA
Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option - Yahoo Finance
Cardiol Therapeutics Inc [CRDL] is 117.03% higher this YTD. Is it still time to buy? - The DBT News
Get in on Cardiol Therapeutics Inc’s (CRDL) buy-in window today! - SETE News
Cardiol Therapeutics closes $13.5M offering - Proactive Investors USA
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares - StockTitan
CRDL’s 2023 Market Dance: Up 90.31% – Time to Invest? - The InvestChronicle
Examining CRDL’s book value per share for the latest quarter - US Post News
Cardiol Therapeutics (TSE:CRDL) Trading Down 19.7%Here's What Happened - MarketBeat
Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today - Benzinga
Cardiol Therapeutics prices $13.5M public offering - Proactive financial news
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares - Investing News Network
Cardiol Therapeutics announces public offering of shares By Investing.com - Investing.com South Africa
Cardiol Therapeutics Announces Public Share Offering - TipRanks
Cardiol Therapeutics announces public offering of shares - Investing.com
SEC Form SUPPL filed by Cardiol Therapeutics Inc. - Quantisnow
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares - Newsfile
TSX Composite Banks Index (TXBA) QuotePress Release - The Globe and Mail
Significant Progress with B7-H3 Targeting Radio-Antibody (BetaBart) - Investing News Network
ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City - The Manila Times
Pericarditis Drugs Market to Boost Revenue Potential, - openPR
Cardiol Therapeutics (OTCMKTS:CRTPF) Shares Down 3.6% - Defense World
Cardiol Therapeutics (TSE:CRDL) Shares Up 1.1% - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Up 1.1% - Defense World
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis - Investing News Network
Cardiol Therapeutics reaches target enrollment for Phase II acute myocarditis trial - Proactive Investors UK
Cardiol Therapeutics’ Landmark Enrollment for Heart Drug Trial - TipRanks
Cirion debuts voice and collaboration service in Chile - Telecompaper EN
Guardion Health Sciences announces executive shake-up - Investing.com India
Returns On Capital At Churchill Downs (NASDAQ:CHDN) Have Stalled - Simply Wall St
Corebridge Financial, Inc. (NYSE:CRBG) Shares Acquired by Hsbc Holdings PLC - Defense World
Federated Hermes Inc. Trims Holdings in Churchill Downs Incorporated (NASDAQ:CHDN) - Defense World
Cuprina Holdings (Cayman) Ltd Plans $16 Million IPO for September 27th (CUPR) - Defense World
Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings) - Benzinga
Renaissance Technologies LLC Decreases Position in Church & Dwight Co., Inc. (NYSE:CHD) - Defense World
FDA Fast Track Designation for Narmafotinib in Advanced Pancreatic Cancer - Investing News Network
Cibus Shares Fall on Plan to Raise $12 Million in Offering - MarketWatch
Cannabinoid Derived Pharmaceutical Market Vendor and Technology Assessment Report 2024-2031 - WhaTech
Research Analysts Issue Forecasts for Cardiol Therapeutics Inc.’s Q3 2024 Earnings (NASDAQ:CRDL) - Defense World
Q3 2024 EPS Estimates for Cardiol Therapeutics Inc. (NASDAQ:CRDL) Lifted by Analyst - MarketBeat
Cardiol Therapeutics (CRDL) Upgraded to Buy: Here's Why - Yahoo Finance
Healthy Upside Potential: Cardiol Therapeutics Inc (CRDL) - SETE News
0.64%
11.36%
자본화:
|
볼륨(24시간):